Barrett & Company’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.81K | Hold |
300
| – | – | ﹤0.01% | 565 |
|
2025
Q1 | $2.13K | Hold |
300
| – | – | ﹤0.01% | 552 |
|
2024
Q4 | $3.5K | Hold |
300
| – | – | ﹤0.01% | 525 |
|
2024
Q3 | $6.17K | Hold |
300
| – | – | ﹤0.01% | 465 |
|
2024
Q2 | $6.71K | Hold |
300
| – | – | ﹤0.01% | 465 |
|
2024
Q1 | $8.25K | Hold |
300
| – | – | ﹤0.01% | 444 |
|
2023
Q4 | $9.15K | Hold |
300
| – | – | 0.01% | 418 |
|
2023
Q3 | $9.49K | Hold |
300
| – | – | 0.01% | 424 |
|
2023
Q2 | $12.2K | Hold |
300
| – | – | 0.01% | 395 |
|
2023
Q1 | $11.2K | Hold |
300
| – | – | 0.01% | 377 |
|
2022
Q4 | $10.5K | Hold |
300
| – | – | 0.01% | 377 |
|
2022
Q3 | $10.5K | Buy |
+300
| New | +$10.5K | 0.01% | 377 |
|